Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Gains 6%; BSE HEALTHCARE Index Up 0.0%
Fri, 2 Aug 10:43

NEULAND LABS Gains 6%; BSE HEALTHCARE Index Up 0.0%Image source: Nikada/www.istockphoto.com

NEULAND LABS share price has zoomed 6% and is presently trading at Rs 9,908.7.

Meanwhile, the BSE HEALTHCARE index is at 40,655.5 .

Among the top gainers in the BSE HEALTHCARE index today are GSK Pharma (up 2.3%) and GRANULES INDIA (up 2.2%).

Jubilant Pharmova (down 2.3%) and MAX HEALTHCARE INSTITUTE (down 1.4%) are among the top losers today.

Over the last one year, NEULAND LABS has moved up from Rs 3,471.7 to Rs 9,908.7, registering a gain of Rs 6,437.0 (up 185.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,655.5, registering a gain of 46.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 124.4%), GSK Pharma (up 101.7%) and SUVEN PHARMACEUTICALS (up 100.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,073.0 (down 1.0%).

The top losers among the BSE Sensex today are Tata Motors (down 3.8%) and Maruti Suzuki (down 3.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,803.7 (down 0.8%). Tata Motors and Maruti Suzuki are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,073.0, registering a gain of 14,545.3 points (up 21.9%).

NEULAND LABS Financial Update...

NEULAND LABS net profit grew 58.2% YoY to Rs 979 million for the quarter ended June 2024, compared to a profit of Rs 619 million a year ago. Net sales rose 21.1% to Rs 4,396 million during the period as against Rs 3,630 million in April-June 2023.

For the year ended March 2024, NEULAND LABS reported 83.5% increase in net profit to Rs 3,001 million compared to net profit of Rs 1,635 million during FY23. Revenue of the company grew 30.8% to Rs 15,586 million during FY24.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 37.8.


Equitymaster requests your view! Post a comment on "NEULAND LABS Gains 6%; BSE HEALTHCARE Index Up 0.0%". Click here!